Skip to Content

Xadago - classification and price?

Responses (1)

masso 16 May 2017

It belongs to the drug class of dopaminergic antiparkinsonism agents.

As for the price call a pharmacy and ask... I am not in the states.

masso 16 May 2017

Xadago (safinamide) Tablets
Company: Newron Pharmaceuticals S.p.A.
Date of Approval: March 21, 2017
Treatment for: Parkinson's Disease

Xadago (safinamide) is a monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

Newron Pharmaceuticals SpA
via Ludovico Ariosto 21,
20091 Bresso (Mi) Italy,
Tel +39 02 610 3461 - Fax +39 02 610 34654
E-mail: free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions